4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-24-025895
Chief Commercial Officer sold 7,852 shares at an average $49.79 ($390,918)
- Chief Commercial Officer acquired 6,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wise John Drayton · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-28 | Sale : show line 1 in the form 10b5-1 | −1,602 | $48.95 | $78,418 | 121,657 | D |
| 2024-05-28 | Exercise or conversion : show line 2 in the form 10b5-1 | +6,250 | $12.58 | $78,625 | 127,907 | D |
| 2024-05-28 | Sale : show line 3 in the form 10b5-1 | −6,250 | $50.00 | $312,500 | 121,657 | D |
| Open-market sales · 7,852 sh · avg $49.79 · $390,918 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-28 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −6,250 | 0 | D |
Loading xslF345X05/wk-form4_1717105566.xml…